VAERS reports by lot

Merck HPV lot 1266U: VAERS reports

89 VAERS reports list lot 1266U as a Merck HPV vaccine, received between 2007-11-08 and 2013-11-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
89
Reports
48%
Marked serious
1
With a death outcome
24
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological7722%
General / Systemic (non-local)6920%
Cardiac / Cardiovascular3310%
Dermatological (non-injection-site)3310%
Musculoskeletal329%
Gastrointestinal298%
Injection-site / Local reaction185%
Autoimmune / Immune-mediated113%
Respiratory113%
Thrombotic / Hematological93%
Allergic / Anaphylactic82%
Reproductive / Menstrual72%
Psychiatric / Neuropsychiatric62%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania12
Massachusetts7
Michigan6
New York6
Illinois5
California4
Ohio4
Texas4
Florida4
West Virginia4
Missouri3
South Dakota3

Reports by month received

2007-111
2007-128
2008-019
2008-0214
2008-032
2008-048
2008-053
2008-062
2008-077
2008-083
2008-094
2008-104
2008-114
2008-124
2009-012
2009-022
2009-035
2009-061
2009-111
2009-121
2010-051
2010-091
2011-011
2013-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.